Professional Summary
Professional Overview
Andy Lewis is an accomplished pharmaceutical research and development leader with over 15 years of experience driving innovation in drug delivery technologies. As the Chief Scientific Officer at Quotient Sciences, he oversees the strategic direction and execution of the company's integrated pharmaceutical development services, focusing on advancing novel drug delivery solutions to improve patient outcomes.
Experience Summary
Current Role
As the Chief Scientific Officer at Quotient Sciences, Andy is responsible for leading the company's scientific and technical strategy, ensuring the delivery of cutting-edge pharmaceutical development solutions to global clients. He collaborates closely with cross-functional teams to identify emerging trends, develop innovative technologies, and drive continuous improvement in Quotient's service offerings. Under his leadership, the company has expanded its expertise in complex drug delivery systems and has become a trusted partner for numerous pharmaceutical and biotech companies.
Career Progression
Prior to his current role, Andy held several senior positions within Quotient Sciences, including SVP of Pharmaceutical Development and Global VP of Integrated Pharmaceutical Sciences. He has also served in leadership roles at other industry-leading organizations, such as Director of Novel Drug Delivery Technologies at Ipsen and Director at Critical Pharmaceuticals. Throughout his career, Andy has consistently demonstrated his ability to translate scientific expertise into practical, commercially viable solutions.
Andy's contributions to the pharmaceutical industry extend beyond his corporate roles. He has been an active member of the Controlled Release Society, serving as Secretary and an At-Large Director of the Board. In these capacities, he has played a pivotal role in shaping the society's strategic direction and promoting advancements in controlled release technologies.
Academic Background
Andy holds a Doctor of Philosophy in Engineering from the University of Nottingham, where he specialized in the development of novel drug delivery systems. He also earned a Bachelor of Pharmacy from the same institution, further strengthening his technical expertise and understanding of the pharmaceutical industry.
Areas of Expertise
- Formulation development and optimization
- Advanced drug delivery technologies, including controlled release, sustained release, and targeted delivery
- Pharmaceutical process development and scale-up
- Quality by Design (QbD) and regulatory compliance
- Multidisciplinary team leadership and collaboration
Professional Impact
Throughout his career, Andy has made significant contributions to the advancement of pharmaceutical development and drug delivery technologies. He has led the successful implementation of several complex projects, delivering innovative solutions that have improved patient accessibility and treatment outcomes. His expertise and thought leadership have been recognized by his peers, as evidenced by his involvement with the Controlled Release Society.
Conclusion
With his extensive experience, technical expertise, and proven track record of driving innovation, Andy Lewis is well-positioned to continue shaping the future of pharmaceutical development as the Chief Scientific Officer at Quotient Sciences. His dedication to enhancing drug delivery solutions and his collaborative approach to problem-solving make him a valuable asset to the industry.
